Skip to main content
Top
Published in: Journal of Interventional Cardiac Electrophysiology 1/2019

01-06-2019 | Cardiac Resynchronization Therapy

Effects of implantation of quadripolar left ventricular leads on CRT response

Authors: Julia W. Erath, Mate Vamos, Dominika Domokos, Alexander P. Benz, Zsolt Bari, Peter Bogyi, Gabor Z. Duray, Stefan H. Hohnloser

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 1/2019

Login to get access

Abstract

Background

The use of quadripolar (QP) left ventricular leads for cardiac resynchronization therapy (CRT) is intended to improve outcomes compared with conventional bipolar leads (BP). Hence, the number of implanted quadripolar CRT systems is increasing despite limited long-term data.

Purpose

The aim of this study is to evaluate clinical response and long-term outcomes of CRT recipients who were implanted with quadripolar versus bipolar left ventricular leads.

Methods

Data from consecutive patients receiving a CRT defibrillator in one German and one Hungarian tertiary referral center were retrospectively collected. Long-term survival and response to CRT were analyzed.

Results

A total of 536 patients with structural heart disease and a mean left ventricular ejection fraction (LVEF) of 25% received a CRT defibrillator (CRT-D) system for primary (79%) or secondary (21%) prevention of sudden death. Comorbidities did not differ significantly between patients receiving a QP (n = 123) or a BP lead (n = 413). Procedure (101 vs. 120 min) and fluoroscopy times (14 vs. 20 min) were shorter in patients implanted with QP compared with BP (both p < 0.001). At 6 months follow-up, QP patients were more likely to respond to CRT measured as improvement in the New York Heart Association (NYHA) functional class (77% vs. 63%; p < 0.001). Use of QP left ventricle/left ventricular (LV) leads was associated with greater reduction in QRS duration compared with patients implanted with BP LV leads (− 21 ± 30 vs. − 8 ± 35 ms, p = 0.004). Mortality was not significantly different between patients with QP and patients with BP LV leads at a mean follow-up of 39 ± 31 months.

Conclusion

Implantation of quadripolar left ventricular leads was associated with better CRT response compared with bipolar left ventricular leads.
Literature
1.
go back to reference Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization therapy in chronic heart failure. N Engl J Med. 2002;346:1845–53.CrossRefPubMed Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization therapy in chronic heart failure. N Engl J Med. 2002;346:1845–53.CrossRefPubMed
2.
go back to reference Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK, et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial. Circulation. 2009;119:969–77.CrossRefPubMed Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK, et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial. Circulation. 2009;119:969–77.CrossRefPubMed
3.
go back to reference Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.CrossRefPubMed Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.CrossRefPubMed
4.
go back to reference Linde C, Abraham WT, Gold MR, Sutton MJ, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. JACC. 2008;52:1834–43.CrossRefPubMed Linde C, Abraham WT, Gold MR, Sutton MJ, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. JACC. 2008;52:1834–43.CrossRefPubMed
5.
go back to reference Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;363:2385–95. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;363:2385–95.
6.
go back to reference Healey JS, Hohnloser SH, Exner DV, Birnie DH, Parkash R, Connolly SJ, et al. RAFT investigators. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the resynchronization for ambulatory heart failure Trial (RAFT). Circ Heart Fail. 2005;5:566–70.CrossRef Healey JS, Hohnloser SH, Exner DV, Birnie DH, Parkash R, Connolly SJ, et al. RAFT investigators. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the resynchronization for ambulatory heart failure Trial (RAFT). Circ Heart Fail. 2005;5:566–70.CrossRef
7.
go back to reference Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.CrossRefPubMed Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.CrossRefPubMed
8.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;27:2129–200.CrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;27:2129–200.CrossRef
9.
go back to reference Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283–352.CrossRefPubMed Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283–352.CrossRefPubMed
10.
go back to reference Sperzel J, Dänschel W, Gutleben KJ, Kranig W, Mortensen P, Connelly D, et al. First prospective, multi-center clinical experience with a novel left ventricular quadripolar lead. Europace. 2012;14:365–72.CrossRefPubMed Sperzel J, Dänschel W, Gutleben KJ, Kranig W, Mortensen P, Connelly D, et al. First prospective, multi-center clinical experience with a novel left ventricular quadripolar lead. Europace. 2012;14:365–72.CrossRefPubMed
11.
go back to reference Dickstein K, Normand C, Auricchio A, Bogale N, Cleland JG, Gitt AK, et al. CRT survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how? Eur J Heart Fail. 2018;20:1039–51.CrossRefPubMed Dickstein K, Normand C, Auricchio A, Bogale N, Cleland JG, Gitt AK, et al. CRT survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how? Eur J Heart Fail. 2018;20:1039–51.CrossRefPubMed
12.
go back to reference Arias MA, Pachon M, Puchol A, Jimenez-Lopez J, Rodriguez-Padia L. Acute and mid-term outcomes of transvenous implant of a new left ventricular quadripolar lead versus bipolar leads for cardiac resynchronization therapy: results from a single-center prospective database. Cardiol J. 2012;19:470–8.CrossRefPubMed Arias MA, Pachon M, Puchol A, Jimenez-Lopez J, Rodriguez-Padia L. Acute and mid-term outcomes of transvenous implant of a new left ventricular quadripolar lead versus bipolar leads for cardiac resynchronization therapy: results from a single-center prospective database. Cardiol J. 2012;19:470–8.CrossRefPubMed
13.
go back to reference Behar JM, Bostock J, Zhu Li AP, Chin HM, Jubb S, Lent E, et al. Cardiac resynchronization therapy delivered via a multipolar left ventricular lead is associated with reduced mortality and elimination of phrenic nerve stimulation: long-term follow-up from a multicenter registry. J Cardiovasc Electrophysiol. 2015;26:540–6.CrossRefPubMedPubMedCentral Behar JM, Bostock J, Zhu Li AP, Chin HM, Jubb S, Lent E, et al. Cardiac resynchronization therapy delivered via a multipolar left ventricular lead is associated with reduced mortality and elimination of phrenic nerve stimulation: long-term follow-up from a multicenter registry. J Cardiovasc Electrophysiol. 2015;26:540–6.CrossRefPubMedPubMedCentral
14.
go back to reference Boriani G, Connors S, Kalarus Z, Lemke B, Mullens W, Asensi JO, et al. Cardiac resynchronization therapy with a quadripolar electrode lead decreases complications at 6 months: Results of the MORE-CRT Randomized Trial. JACC EP. 2016;2:212–20. Boriani G, Connors S, Kalarus Z, Lemke B, Mullens W, Asensi JO, et al. Cardiac resynchronization therapy with a quadripolar electrode lead decreases complications at 6 months: Results of the MORE-CRT Randomized Trial. JACC EP. 2016;2:212–20.
15.
go back to reference Turakhia M, Cao M, Fischer A, Nabutovsky Y, Sloman LS, Dalal N, et al. Reduced mortality associated with quadripolar compared to bipolar left ventricular leads in cardiac resynchronization therapy. JACC EP. 2016;2:426–33. Turakhia M, Cao M, Fischer A, Nabutovsky Y, Sloman LS, Dalal N, et al. Reduced mortality associated with quadripolar compared to bipolar left ventricular leads in cardiac resynchronization therapy. JACC EP. 2016;2:426–33.
16.
go back to reference Rijal S, Wolfe J, Rattan R, Durrani A, Althouse AD, Marroquin OC, et al. Lead related complications in quadripolar versus bipolar left ventricular leads. Indian Pacing Electrophysiol J. 2017;17:3–7.CrossRefPubMed Rijal S, Wolfe J, Rattan R, Durrani A, Althouse AD, Marroquin OC, et al. Lead related complications in quadripolar versus bipolar left ventricular leads. Indian Pacing Electrophysiol J. 2017;17:3–7.CrossRefPubMed
17.
go back to reference Forleo GB, Mantica M, Di Biase L, Panattoni G, Della Rocca DG, Papavasileiou LP, et al. Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study. Heart Rhythm. 2012;9:1822–8.CrossRefPubMed Forleo GB, Mantica M, Di Biase L, Panattoni G, Della Rocca DG, Papavasileiou LP, et al. Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study. Heart Rhythm. 2012;9:1822–8.CrossRefPubMed
18.
go back to reference Bencardino G, Di Monaco A, Russo E, Colizzi C, Perna F, Pelargonio G, et al. Outcome of patients treated by cardiac resynchronization therapy using a quadripolar left ventricular lead. Circ J. 2012;80:613–8.CrossRef Bencardino G, Di Monaco A, Russo E, Colizzi C, Perna F, Pelargonio G, et al. Outcome of patients treated by cardiac resynchronization therapy using a quadripolar left ventricular lead. Circ J. 2012;80:613–8.CrossRef
19.
go back to reference Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2013;34:2281–32.CrossRefPubMed Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2013;34:2281–32.CrossRefPubMed
Metadata
Title
Effects of implantation of quadripolar left ventricular leads on CRT response
Authors
Julia W. Erath
Mate Vamos
Dominika Domokos
Alexander P. Benz
Zsolt Bari
Peter Bogyi
Gabor Z. Duray
Stefan H. Hohnloser
Publication date
01-06-2019
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 1/2019
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-019-00545-8

Other articles of this Issue 1/2019

Journal of Interventional Cardiac Electrophysiology 1/2019 Go to the issue